CONFLUENCE LIFE SCIENCES

confluence-life-sciences-logo

CLS is a drug discovery company focusing on rational drug design to discover and develop mechanistically novel kinase inhibitors for use in both human and animal health care. CLSโ€™s kinase inhibitors target key signal transduction enzymes involved in the regulation of cancer growth and survival, or in the modulation of chronic inflammation. Unlike many other kinase inhibitor programs, however, CLS is targeting novel binding sites (on kinase targets that have proved challenging) as well as pre... viously โ€œun-druggedโ€ kinases. Driving CLS success in this effort is a team of world-class experts with extensive Pharma experience in kinase inhibitor discovery and development. CLS provides this team with the opportunity to pursue strategies and targets outside Pharmaโ€™s traditional focus. In addition, scientific and business collaborations are being established to enable the success of the business. The strategy is to develop and maintain a program pipeline: discover, develop, partner, repeat.

#People #Financial #Website #More

CONFLUENCE LIFE SCIENCES

Industry:
Biotechnology Health Care Life Science Medical

Founded:
2010-01-01

Address:
St Louis, Missouri, United States

Country:
United States

Website Url:
http://www.confluencelifesciences.com

Total Employee:
11+

Status:
Active

Contact:
(314) 932-4032

Email Addresses:
[email protected]

Total Funding:
13.7 M USD

Technology used in webpage:
SPF Apple Mobile Web Clips Icon OpenResty Network Solutions DNS Mimecast Network Solutions



Current Advisors List

danny-janiak_image

Danny Janiak Board Member @ Confluence Life Sciences
Board_member

Current Employees Featured

joseph-monahan_image

Joseph Monahan
Joseph Monahan Chief Scientific Officer & Founder @ Confluence Life Sciences
Chief Scientific Officer & Founder
2010-01-01

paul-changelian_image

Paul Changelian
Paul Changelian Director of Biology @ Confluence Life Sciences
Director of Biology
2014-09-01

Founder


joseph-monahan_image

Joseph Monahan

Investors List

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series B - Confluence Life Sciences

st-louis-arch-angels_image

St. Louis Arch Angels

St. Louis Arch Angels investment in Series B - Confluence Life Sciences

missouri-technology-corporation_image

Missouri Technology Corporation

Missouri Technology Corporation investment in Series B - Confluence Life Sciences

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Series B - Confluence Life Sciences

biogenerator_image

BioGenerator

BioGenerator investment in Series B - Confluence Life Sciences

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series A - Confluence Life Sciences

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Series A - Confluence Life Sciences

biogenerator_image

BioGenerator

BioGenerator investment in Series A - Confluence Life Sciences

helix-fund_image

Helix Fund

Helix Fund investment in Series A - Confluence Life Sciences

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Series A - Confluence Life Sciences

Official Site Inspections

http://www.confluencelifesciences.com

  • Host name: vux.netsolhost.com
  • IP address: 206.188.192.194
  • Location: Jacksonville United States
  • Latitude: 30.1426
  • Longitude: -81.5727
  • Metro Code: 561
  • Timezone: America/New_York
  • Postal: 32258

Loading ...

More informations about "Confluence Life Sciences"

Confluence Life Sciences - VentureRadar

Confluence Life Sciences, Inc. is a technology-based company focusing on rational drug design to identify proprietary, mechanistically novel drugs. Confluence has assembled a team of world โ€ฆSee details»

Confluence Life Sciences - Ownership and Business Overview

Aug 8, 2017 Confluence Life Sciences, Inc. is a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological โ€ฆSee details»

Confluence Life Sciences - Company Profile - Tracxn

Dec 7, 2024 Confluence Life Sciences - Kinase drugs for cancer, autoimmune and inflammatory diseases using its technology. Acquired by Aclaris Therapeutics. Raised a total funding of โ€ฆSee details»

Confluence Life Sciences LLC - Company Profile and News

Confluence Life Sciences, Inc. (CLS) focuses on drug design and discovery. The Company specializes in mechanistically novel inhibitors, targeting transduction enzymes involved in the โ€ฆSee details»

Confluence Life Sciences, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Confluence Life Sciences, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»

Confluence Life Sciences - Crustdata Company Profile, Funding โ€ฆ

Unlock insights on Confluence Life Sciences and 2M+ companies now! Request Demo. About . Confluence Life Sciences. CLS is a drug discovery company focusing on rational drug design โ€ฆSee details»

Confluence Life Sciences - Contacts, Employees, Board

Organization. Confluence Life Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of โ€ฆSee details»

Confluence Life Sciences - Golden

Confluence Life Sciences. A company dedicated to drug designs to develop kinase inhibitors for healthcare of human and animals. Overview Structured Data Issues Contributors Activity. โ€ฆSee details»

Confluence Life Sciences | CipherBio

Explore Confluence Life Sciences's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Confluence Life Sciences Inc. - BioCentury Company Profiles - BCIQ

Confluence Life Sciences Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Confluence Life Sciences - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - Confluence โ€ฆSee details»

BioGenerator-Backed Confluence Life Sciences Achieves ... - BioSTL

Confluence Life Sciences was BioGeneratorโ€™s first lab tenant and continues to carry out its research there under the leadership of Joe Monahan and Walter Smith, former Pfizer โ€ฆSee details»

Confluence Life Sciences - News & Media - BioGenerator

Confluence Life Sciences. Overview. Confluence, now publicly traded Aclaris Therapeutics, is a clinical­ stage biopharmaceutical company developing a pipeline of novel drug candidates to โ€ฆSee details»

BioSTL - Congrats to Confluence Life Sciences, a portfolio.

Congrats to Confluence Life Sciences, a portfolio company of BioSTL's venture development organization, the BioGenerator, on winning a $289,278 Small Business Innovation Research โ€ฆSee details»

Confluence Life Sciences - Crunchbase

Confluence Life Sciences and Novellus both operate in the biotechnology sector. Confluence Life Sciences focuses on rational drug designs for kinase inhibitors in human and animal โ€ฆSee details»

Confluence Life Sciences Venture Capital and Private Equity โ€ฆ

Confluence Life Sciences. 4320 Forest Park Ave., Suite 303. St. Louis, MO 63108. Phone: 314-932-4032. www.confluencelifesciences.com. Confluence Life Sciences is a drug discovery and โ€ฆSee details»

BioGenerator Company Confluence Acquired by Aclaris

Confluence Life Sciences was BioGeneratorโ€™s first lab tenant and continues to carry out its research there under the leadership of Joe Monahan and Walter Smith, former Pfizer โ€ฆSee details»

Confluence Life Sciences | CipherBio

Explore Confluence Life Sciences's investment information, scientific platforms, therapeutic approaches, indications and more here! Home. PRO Data. Investor Insights. Investors & VCs โ€ฆSee details»

Confluence Life Sciences - Tech Stack, Apps, Patents & Trademarks

Nov 24, 2024 Confluence Life Sciences uses 8 technology products and services including HTML5, Comodo PositiveSSL Certificates, and Modernizr, according to G2 Stack. Confluence โ€ฆSee details»

linkstock.net © 2022. All rights reserved